Feb 18, 2016 10:49am EST OPKO Health to Present at the RBC Capital Markets Global Healthcare Conference
Feb 09, 2016 8:30am EST Study Demonstrates OPKO’s 4Kscore Test Reduces Unnecessary Prostate Biopsies While Improving Risk Prediction for Aggressive Prostate Cancer
Dec 21, 2015 8:30am EST OPKO’s GeneDx Study of More Than 10,000 Individuals Tested with Multigene NGS Hereditary Cancer Panel Reveals New Risks
Dec 09, 2015 8:30am EST OPKO’s GeneDx Study Demonstrates Whole Exome Sequencing Usefulness In Diagnosing Rare Disorders
Nov 17, 2015 12:31pm EST OPKO Health to Present at the Jefferies Autumn 2015 Global Healthcare Conference
Nov 16, 2015 11:26am EST OPKO Licensee TESARO Announces the Launch of VARUBI(TM) (Rolapitant) in the United States